Development and Validation of a Prognostic Nomogram for Severe Postpartum Haemorrhage After Caesarean Delivery: A Two-Centre Retrospective Study

preprint OA: closed
📄 Open PDF View at publisher
⚙ AI-generated summary by claude@2026-07, 2026-07-15 ⓘ

This study developed and validated a nomogram using pre-pregnancy weight, previous cesarean delivery, placenta previa, and placenta accreta spectrum disorders to predict severe postpartum hemorrhage after cesarean delivery.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstract Objective: To develop and validate a nomogram to predict severe postpartum haemorrhage (PPH) following caesarean delivery. Design: Two-centre retrospective cohort study. Setting: Third Affiliated Hospital of Guangzhou Medical University and the Dongguan Maternal and Child Health Care Hospital. Population: Cesarean delivery patients from the Third Affiliated Hospital of Guangzhou Medical University were divided into a development cohort (n=11,037) and an internal validation cohort (n=4,673). Cesarean delivery patients from the Dongguan Maternal and Child Health Care Hospital (n=13,775) were enrolled in the external validation cohort. Methods: The nomogram was based on independent risk factors for severe PPH obtained by multivariate logistic regression. We evaluated the discrimination and calibration of the nomogram in the development and validation cohorts. The area under the receiver operating characteristic curve, the Hosmer-Lemeshow test, and calibration plots were used to assess the nomogram. Main outcome measures: Postpartum haemorrhage. Results: Severe PPH occurred in 4.5%, 4.3%, and 2.0% of the patients in the development, internal validation, and external validation cohorts, respectively. The nomogram used data including previous caesarean delivery, low pre-pregnancy weight, placenta previa, and placenta accreta spectrum disorders. The area under the curves of the nomogram in the internal and external validation cohorts were 0.915 (95% confidence interval, 0.893–0.938) and 0.799 (95% confidence interval, 0.764–0.834), respectively. Consistency between the predicted and actual probabilities was observed in both validation cohorts. Conclusions: The nomogram displayed good calibration and discrimination; thus, it can be used for screening and timely intervention by clinicians, thereby reducing severe PPH incidence.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-06-05T02:00:03.366016+00:00